RxDoctor Payments Data

Nana Yaw Darkwa, MD

Hospitalist · Milford, DENPI 1770607376

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $143, more than ten times the $11 reported in 2019. Among hospitalist clinicians in DE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$533in general payments, 2019–2025

Across 26 payments — averaging $20.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$121
  • Kestra Medical Technology Services, Inc.$109
  • Merck$101
  • E.r. Squibb & Sons, L.L.C.$96
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$38
  • Medtronic$25
  • plus $42 from 2 others

What the payments were for

  • Food & beverage$533100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$533 in reported general payments places this provider in the 90th percentile of 43 hospitalist providers in Delaware.

See all hospitalist providers in Delaware

Medicare billing

Part B allowed, 2024
$112,734
Medicare patients
329
Services billed
1,069

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin28$19,075
Carbamazepine ErCarbamazepine13$1,223
Ranolazine ErRanolazine12$796
Atorvastatin Calcium58$627
Nitroglycerin32$376
Doxycycline Monohydrate23$368
ClopidogrelClopidogrel Bisulfate38$306
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav35$283
Pantoprazole Sodium26$268
Isosorbide Mononitrate ErIsosorbide Mononitrate42$247
Carvedilol22$191
Metoprolol Succinate19$150
Losartan Potassium23$145
Hydralazine Hcl19$119
Ezetimibe14$100

Paid to pharmacies, not to this prescriber.

Other hospitalist in Milford

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →